Arvest Investments Inc. Trims Stake in Keurig Dr Pepper, Inc $KDP

Arvest Investments Inc. lowered its stake in Keurig Dr Pepper, Inc (NASDAQ:KDP) by 1.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 30,549 shares of the company’s stock after selling 554 shares during the quarter. Arvest Investments Inc.’s holdings in Keurig Dr Pepper were worth $1,010,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of KDP. Vanguard Group Inc. lifted its stake in Keurig Dr Pepper by 21.3% in the 1st quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company’s stock valued at $4,962,338,000 after buying an additional 25,425,644 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Keurig Dr Pepper by 108.1% in the 1st quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company’s stock valued at $1,330,565,000 after buying an additional 20,196,835 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Keurig Dr Pepper by 981.3% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,514,608 shares of the company’s stock valued at $86,050,000 after buying an additional 2,282,050 shares in the last quarter. Seven Grand Managers LLC purchased a new stake in Keurig Dr Pepper in the 1st quarter valued at approximately $51,330,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Keurig Dr Pepper by 15.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 9,260,957 shares of the company’s stock valued at $297,462,000 after buying an additional 1,258,062 shares in the last quarter. Hedge funds and other institutional investors own 93.99% of the company’s stock.

Insider Transactions at Keurig Dr Pepper

In other Keurig Dr Pepper news, Director Robert James Gamgort sold 7,601 shares of the business’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $35.91, for a total transaction of $272,951.91. Following the completion of the sale, the director owned 2,284,568 shares of the company’s stock, valued at approximately $82,038,836.88. The trade was a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the business’s stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the sale, the insider directly owned 82,511 shares of the company’s stock, valued at approximately $2,777,320.26. This trade represents a 12.70% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 459,601 shares of company stock valued at $15,228,872. 0.40% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on KDP shares. HSBC reaffirmed a “hold” rating and issued a $30.00 target price (down previously from $42.00) on shares of Keurig Dr Pepper in a research note on Tuesday, August 26th. Hsbc Global Res downgraded Keurig Dr Pepper from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 26th. Barclays boosted their price target on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Monday, July 28th. UBS Group cut their price target on Keurig Dr Pepper from $40.00 to $35.00 and set a “buy” rating for the company in a report on Wednesday, August 27th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on Keurig Dr Pepper from $40.00 to $38.00 and set a “buy” rating for the company in a report on Tuesday, August 26th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $38.38.

Keurig Dr Pepper Price Performance

KDP stock opened at $27.23 on Friday. The stock has a 50-day moving average price of $32.35 and a two-hundred day moving average price of $33.26. Keurig Dr Pepper, Inc has a 12-month low of $27.01 and a 12-month high of $38.28. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. The company has a market cap of $36.99 billion, a PE ratio of 24.31, a price-to-earnings-growth ratio of 1.51 and a beta of 0.47.

Keurig Dr Pepper (NASDAQ:KDP) last posted its quarterly earnings results on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The firm had revenue of $4.16 billion during the quarter, compared to the consensus estimate of $4.14 billion. During the same quarter in the previous year, the business earned $0.45 earnings per share. The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. As a group, research analysts predict that Keurig Dr Pepper, Inc will post 1.92 EPS for the current year.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.